Pheochromocytoma: A three-decade clinical experience in a multicenter study

Pheochromocytoma: A three-decade clinical experience in a multicenter study

To analyze the clinical and analytical features, diagnostic tests, therapies, and outcomes of pheochromocytoma (PCC). A multicenter retrospective study in surgically treated patients with PCC followed in 3 Spanish tertiary referral hospitals. A total of 106 patients (61 [57.5%] women, mean age 52.3 ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista clínica espanõla (English edition) 2021-01, Vol.221 (1), p.18-25
Hauptverfasser: Iglesias, P., Santacruz, E., García-Sancho, P., Marengo, A.P., Guerrero-Pérez, F., Pian, H., Fajardo, C., Villabona, C., Díez, J.J.
Format: Artikel
Sprache:eng
Schlagworte:
Enfermedad de von Hippel-Lindau
Feocromocitoma
Multiple endocrine neoplasia
Neoplasia endocrina múltiple
Neurofibromatosis tipo 1
Neurofibromatosis type 1
Pheochromocytoma
Von Hippel-Lindau disease
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To analyze the clinical and analytical features, diagnostic tests, therapies, and outcomes of pheochromocytoma (PCC). A multicenter retrospective study in surgically treated patients with PCC followed in 3 Spanish tertiary referral hospitals. A total of 106 patients (61 [57.5%] women, mean age 52.3 ± 14.8 years) were evaluated. At diagnosis, PCC was symptomatic in 62% and sporadic in 83%. Patients with familial PCC were significantly younger than those with sporadic disease (40.8 ± 14.2 years vs 54.5 ± 13.9 years, p 
ISSN:2254-8874
2254-8874
DOI:10.1016/j.rceng.2019.12.011